Navigation Links
Favrille to Present at BIO InvestorForum
Date:10/2/2007

Live Webcast from the Palace Hotel in San Francisco on Wednesday, October

10th

SAN DIEGO, Oct. 2 /PRNewswire-FirstCall/ -- Favrille, Inc. (Nasdaq: FVRL), a biopharmaceutical company developing patient-specific, active immunotherapies for the treatment of cancer, today announced that Tamara Seymour, Chief Financial Officer, will present at the Biotechnology Industry Organization (BIO) InvestorForum at 10:15 a.m. Pacific time on Wednesday, October 10, 2007. The conference will be held at the Palace Hotel in San Francisco.

(Logo: http://www.newscom.com/cgi-bin/prnh/20031013/LAM095LOGO)

Ms. Seymour will provide an overview of Favrille and the clinical trials of its lead compound, FavId(R), which is currently in a pivotal Phase 3 clinical trial for the treatment of follicular B-cell non-Hodgkin's lymphoma (NHL). A live webcast of the presentation can be accessed at http://www.favrille.com. The replay will be available approximately one hour after the presentation and will be archived until November 10, 2007.

About Favrille, Inc.

Favrille, Inc. is a biopharmaceutical company focused on the development and commercialization of targeted immunotherapies for the treatment of cancer and other diseases of the immune system. The Company's lead product candidate, FavId, is based upon unique genetic information extracted from a patient's tumor. FavId is currently under investigation in a pivotal Phase 3 clinical trial for patients with follicular B-cell NHL and Phase 2 clinical trials in other B-cell NHL indications. The Company is developing additional applications based on its immunotherapy expertise and proprietary cost-effective manufacturing technology, including a second product candidate, FAV-201, for the treatment of cutaneous T-cell lymphoma.


'/>"/>
SOURCE Favrille, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
2. Wisconsin firms to present at Cleantech venture capital event
3. New Sonic Foundry search engine finds words, phrases in video presentations
4. Lone Wisconsin firm to present at InvestMidwest
5. Sonic Foundry creates search engine for 7,000 expert video presentations
6. InvestMidWest calls for business presentations
7. Wicab to present BrainPort at Boston conference
8. Three more Wisconsin firms to present at venture forum
9. Six Wisconsin firms to present at BIO Mid-America VentureForum
10. New Health and Human Services representative for Midwest
11. Top 20 big pharmas represent majority of world pharma market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... , June 18, 2013 ... release of the HELM biomolecular representation standard software ... MIT licence. HELM (Hierarchical Editing Language ... range of biomolecules (e.g. proteins, nucleotides, antibody drug ... and sequence-based informatics methodologies impractical or unusable. HELM ...
(Date:6/18/2013)... , June 18, 2013 Mapi ... (APIs), generic and innovative intermediates, and finished dosage forms based ... has been granted a United States ... Europe for the oral treatment of ... is titled Intermediate Compounds and Processes for the Preparation ...
(Date:6/18/2013)... , June 18, 2013   Lexicon Pharmaceuticals, ... biopharmaceutical company focused on discovering breakthrough treatments for ... has joined the company as its vice ... Northcott brings extensive commercial experience to Lexicon, including ... variety of therapeutic areas. Mr. Northcott ...
(Date:6/18/2013)... June 18, 2013 New user friendly ... 200 prevent the dangers of misuse and ineffective ... knobs, analog pressure gauges, hot surfaces and complex door ... a new, modern autoclave, Revolutionary Science explains some important ... Older autoclave designs will recycle dirty water. ...
Breaking Biology Technology:The Pistoia Alliance Releases HELM Biomolecular Representation Standard Open Source Tools 2Mapi Pharma Granted United States Patent for Pain Relief Medication "Tapentadol" 2John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations 2John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations 3How to Autoclave: Why the User Friendliness of the Saniclave 200 is So Important Today 2
... Neogen Corporation (NASDAQ: NEOG ) announced today ... seafood testing laboratory from its parent company, GlycoMar Ltd. ... services to the shellfish and salmon aquaculture industries. VeroMara,s ... including E. coli , noroviruses, and salmon husbandry. ...
... 2011 , Kuros Biosurgery AG, ... biomaterials and bioactive-biomaterial,combination products for trauma, wound and ... Application,00910049 by the European Patent Office. This now ... broad portfolio of applications,and patents designed to protect ...
... TRIANGLE PARK, N.C., June 17, 2011 Max ... the prestigious Max Group whose sister-company, Max Healthcare ... of Minimal Access, Metabolic & Bariatric Surgery, accredited ... Surgical Review Corporation (SRC), USA.  The institute has ...
Cached Biology Technology:Neogen Acquires VeroMara from GlycoMar Ltd. 2Kuros Announces Allowance of European Patent for Synthetic Biomaterials 2Kuros Announces Allowance of European Patent for Synthetic Biomaterials 3Max Institute of Minimal Access, Metabolic & Bariatric Surgery Accredited as an International Centre of Excellence for Minimal Invasive Surgery 2
(Date:6/18/2013)... New research from the University of Adelaide shows that ... a baby,s life is linked to a higher IQ at early ... Public Health researchers, who analysed data from more than 13,800 children ... Pediatrics , show that babies who put on ... IQ 1.5 points higher by the time they were six years ...
(Date:6/17/2013)... Researchers have identified a new virus in patients with ... to determine whether the virus is responsible for the ... a total of 28 out of 644 patients with ... 4%, but not in any of the 122 patients ... of the brain and central nervous system are often ...
(Date:6/17/2013)... June 6, professors in Wayne State University,s Department ... Foundation-funded (NSF) Research Experience for Undergraduates (REU) program. ... to do cutting-edge research in astrophysics, and in ... Alexey Petrov, Ph.D., professor of physics in Wayne ... and program director of the grant, the student ...
Breaking Biology News(10 mins):IQ link to baby's weight gain in first month 2New virus isolated from patients with severe brain infections 2New virus isolated from patients with severe brain infections 3Wayne State welcomes undergraduates from around the US for physics research experience 2
... certain enzyme can resist the normal effects of a heart ... and still-oxygenated heart tissue, according to a study by researchers ... the possibility of a therapy that could stimulate the growth ... as well as prevent an attack from occurring at all, ...
... Researchers at the Department of Energy,s Oak Ridge National ... at how developing nerve cells may hold a key ... and Parkinson,s disease. St. Jude scientists have linked ... the brains and retinas of young mice to certain ...
... damage can be triggered by various insults, including hepatitis ... can lead to cancer. A new study by researchers ... reveals how one protein helps decide the fate of ... online on March 30th in the Journal of ...
Cached Biology News:A missing enzyme conveys major heart protection in pre-clinical work 2A missing enzyme conveys major heart protection in pre-clinical work 3ORNL, St. Jude track neurons to predict and prevent disease 2
... peptide derived from the C-terminal region of ... D iris-expressed growth factor spinal cord-derived growth ... rat by one amino acid replacement. ... mouse and rat PDGF-D proteins. Reactivity: ...
Antibodies were affinity purified using epitopes specific to USP33 immobilized on solid support....
...
... 100% ,human IgG subclass 2 ... 100% ,human IgG subclass 4 ... 100% ,human IgG Fc ... IgG Fab ...
Biology Products: